• Explore /
  • Poster
  • / NSABP B-41, a randomized neoadjuvant trial: Genes and signatures associated with pathologic complete response (pCR).

NSABP B-41, a randomized neoadjuvant trial: Genes and signatures associated with pathologic complete response (pCR).

Abstract Poster

Authors

Sandra Swain

Sandra M. Swain

NSABP, and Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC

Sandra M. Swain , Gong Tang , Heather Ann Brauer , David Goerlitz , Peter C. Lucas , Brent T. Harris , Andre Robidoux , Charles E. Geyer Jr., Priya Rastogi , Eleftherios P. Mamounas , Norman Wolmark

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Breast Cancer—Local/Regional/Adjuvant

Track

Breast Cancer

Sub Track

Neoadjuvant Therapy

Citation

J Clin Oncol 37, 2019 (suppl; abstr 511)

DOI

10.1200/JCO.2019.37.15_suppl.511

Abstract #

511

Poster Bd #

3

Abstract Disclosures

Similar Posters

First Author: Sandra M. Swain

First Author: Rebecca Arielle Shatsky

First Author: M. Luque

First Author: Christian F. Singer